上海凯宝(300039.SZ)2021年度净利润预增30%-60%
格隆汇1月20日丨上海凯宝(300039.SZ)公布,预计2021年度归属于上市公司股东的净利润1.38亿元-1.70亿元,同比增长30%-60%;扣除非经常性损益后的净利润1.24亿元-1.53亿元,同比增长30%-60%。
2021年,新冠肺炎疫情逐步得到控制,全国医疗机构的诊疗服务陆续恢复,但新冠肺炎疫情的不确定性,对公司带来的影响依然存在。公司积极应对,按照年度经营计划有序推进各项工作,总体经营情况保持稳定,归属于上市公司股东的净利润较去年同期实现平稳增长。
报吿期,预计非经常性损益对净利润的影响金额为1050万元左右,上年度非经常性损益对净利润的影响金额为1044.73万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.